Usama Gergis, MD, MBA
Director, Bone Marrow Transplant & Immune Cellular Therapy
Professor
Contact
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Usama Gergis, MD, MBA
Director, Bone Marrow Transplant & Immune Cellular Therapy
Professor
Research & Clinical Interest
My research is focused on high-risk myeloid malignancies, Graft versus Host Disease (GVHD), and hematopoietic stem cell transplantation for patients who lack matched donors. I specialize in treating a wide spectrum of bone marrow failure syndromes with conventional and novel agents to broaden the spectrum of eligible patients for this potentially curative treatment. My clinical interests include allogeneic and autologous stem cell transplant and immunotherapy for the treatment of hematologic cancers.
Education
Medical School
MB, Chb, Cairo University School of Medicine, Cairo, Egypt, 1996
Residency
Brooklyn Hospital-Weill Cornell Medical College, Brooklyn, NY, 2003
Fellowship
Hematology and Medical Oncology, Brooklyn Hospital-Weill Cornell Medical College, Brooklyn, NY, 2006
Bone Marrow Transplantation, Lee Moffitt Cancer and Research Institute, University of South Florida, Tampa, FL 2007
Additional Education
MBA, Samuel Curtis Johnson Graduate School of Management at Cornell University, New York, NY, 2017
Publications
- A Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant, Results of a Prospective Trial
- Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
- A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose
- Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study
- Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
Certifications
American Board of Hematology, 2006
American Board of Clinical Oncology, 2006
American Board of Internal Medicine, 2003